NuGEN Granted Patent for RNA Amplification Technology
News Sep 21, 2005
NuGEN Technologies, Inc. has announced that the United States Patent and Trademark Office issued U.S. Patent No. 6,946,251 entitled, "Methods and Compositions for Amplification of RNA Sequences."
This patent establishes protection around the company's innovative linear, isothermal RNA amplification technology which has widespread applications in life science research, therapeutic and diagnostics.
The patent covers methods, applications and kits, and provides protection for NuGEN's Ribo-SPIA™ methods and reagents that power NuGEN's Ovation™ family of products.
The Ovation™ System is designed to provide methods and reagents for both 3' based RNA amplification and whole transcriptome amplification.
Unlike the commonly used RNA amplification methods that are based on in vitro transcription, Ribo-SPIA™ is a single round amplification that is designed to provide efficient amplification to generate microgram amounts of cDNA products from minute (nanogram level and lower) amounts of total RNA.
NuGEN's isothermal nucleic acid amplification technologies are protected by a number of U.S. and foreign issued patents and patent applications.
Bioethics Council Rules Heritable Genome Editing "Ethically Acceptable" In Certain CircumstancesNews
A leading UK bioethics advisory body has weighed in on the debate around human genetic modification, concluding that heritable genome editing – modifying the DNA of an egg, sperm or embryo with changes that will be passed on to future generations – could be ‘morally permissible’ in humans, provided key ethical tests are met.
Genetic Factors Leading to Rare Bone Fusion Disorder IdentifiedNews
Genome sequencing establishes multiple genes responsible for a rare condition that cause bone fusionREAD MORE
Hay Fever Risk Genes Overlap with Autoimmune DiseaseNews
In a large international study involving almost 900,000 participants, researchers from the University of Copenhagen and COPSAC have found new risk genes for hay fever. It is the largest genetic study so far on this type of allergy, which affects millions of people around the world.READ MORE